Experienced in IgG4-Related Disease

Dr. Vivek Nagaraja

Rheumatology
Mayo Clinic Building SCT-1
13400 E Shea Blvd, 
Scottsdale, AZ 
Accepting New Patients
Offers Telehealth

Experienced in IgG4-Related Disease
Mayo Clinic Building SCT-1
13400 E Shea Blvd, 
Scottsdale, AZ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Vivek Nagaraja is a Rheumatologist in Scottsdale, Arizona. Dr. Nagaraja is rated as an Experienced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Scleroma, and Scleredema. Dr. Nagaraja is currently accepting new patients.

His clinical research consists of co-authoring 36 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in MI
Hospital Affiliations
Mayo Clinic Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MercyCare
  • EPO
  • HMO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Mayo Clinic Building SCT-1
13400 E Shea Blvd, Scottsdale, AZ 85259
Call: 480-301-8000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Drug
Study Drug: Iloprost
Study Phase: Phase 3
Evaluation of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis BRAVOS: A Phase 1/2 Multicenter Randomized, Double Blinded, Safety Study (ITN075AI)
Evaluation of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis BRAVOS: A Phase 1/2 Multicenter Randomized, Double Blinded, Safety Study (ITN075AI)
Enrollment Status: Completed
Publish Date: May 17, 2024
Intervention Type: Biological
Study Drug: Brentuximab vedotin
Study Phase: Phase 1/Phase 2
Scleroderma Lung Study III (SLS III): Combining the Anti-fibrotic Effects of Pirfenidone (PFD) With Mycophenolate (MMF) for Treating Scleroderma-related Interstitial Lung Disease
Scleroderma Lung Study III (SLS III): Combining the Anti-fibrotic Effects of Pirfenidone (PFD) With Mycophenolate (MMF) for Treating Scleroderma-related Interstitial Lung Disease
Enrollment Status: Completed
Publish Date: December 15, 2023
Intervention Type: Drug
Study Drugs: Pirfenidone, Mycophenolate Mofetil
Study Phase: Phase 2
A Multi-Center Cluster Randomized Controlled Clinical Trial to Determine the Impact of a Mobile Health Application on Rheumatoid Arthritis Shared Decision Making
A Multi-Center Cluster Randomized Controlled Clinical Trial to Determine the Impact of a Mobile Health Application on Rheumatoid Arthritis Shared Decision Making
Enrollment Status: Completed
Publish Date: June 22, 2023
Intervention Type: Behavioral
Study Phase: Not Applicable
A Multi-center, Randomized, Double-blind (Sponsor Open), Placebo-controlled, Repeat-dose, Proof of Mechanism Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Explore Efficacy of GSK2330811 in Participants With Diffuse Cutaneous Systemic Sclerosis
A Multi-center, Randomized, Double-blind (Sponsor Open), Placebo-controlled, Repeat-dose, Proof of Mechanism Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Explore Efficacy of GSK2330811 in Participants With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Completed
Publish Date: May 24, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 29, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
View 6 Less Clinical Trials

35 Total Publications

The Effectiveness of Sacubitril/Valsartan in Systemic Sclerosis Patients with Heart Failure: A Retrospective Analysis.
The Effectiveness of Sacubitril/Valsartan in Systemic Sclerosis Patients with Heart Failure: A Retrospective Analysis.
Journal: Journal of clinical medicine
Published: April 28, 2025
View All 35 Publications
Similar Doctors
Distinguished in IgG4-Related Disease
Dr. Nehad R. Soloman
Rheumatology
Distinguished in IgG4-Related Disease
Dr. Nehad R. Soloman
Rheumatology

Arizona Arthritis And Rheumatology Associates P C

4550 E Bell Rd, Suite 170, 
Phoenix, AZ 
 (11.5 miles away)
480-443-8400
Languages Spoken:
English, Arabic, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Nehad Soloman is a Rheumatologist in Phoenix, Arizona. Dr. Soloman is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Rheumatoid Arthritis (RA), IgG4-Related Disease, Light Chain Deposition Disease (LCDD), and MAGIC Syndrome. Dr. Soloman is currently accepting new patients.

Distinguished in IgG4-Related Disease
Dr. Alexander C. Hu
Rheumatology
Distinguished in IgG4-Related Disease
Dr. Alexander C. Hu
Rheumatology

Arizona Arthritis And Rheumatology Associates P C

4550 E Bell Rd, Suite 170, 
Phoenix, AZ 
 (11.5 miles away)
480-443-8400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Alexander Hu is a Rheumatologist in Phoenix, Arizona. Dr. Hu is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, Gout, and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. Dr. Hu is currently accepting new patients.

Distinguished in IgG4-Related Disease
Dr. Mark M. Freijat
Rheumatology | Hospital Medicine
Distinguished in IgG4-Related Disease
Dr. Mark M. Freijat
Rheumatology | Hospital Medicine
7425 E Shea Blvd, Suite 100, 
Scottsdale, AZ 
 (7.3 miles away)
480-613-3569
Languages Spoken:
English, Arabic, Italian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Freijat is a Rheumatologist and a Hospital Medicine provider in Scottsdale, Arizona. Dr. Freijat is rated as an Advanced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are IgG4-Related Disease, Light Chain Deposition Disease (LCDD), MAGIC Syndrome, and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. Dr. Freijat is currently accepting new patients.

VIEW MORE IGG4-RELATED DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nagaraja's expertise for a condition
ConditionClose
  • Elite
  • Scleroderma
    Dr. Nagaraja is
    Elite
    . Learn about Scleroderma.
    See more Scleroderma experts
  • Systemic Sclerosis (SSc)
    Dr. Nagaraja is
    Elite
    . Learn about Systemic Sclerosis (SSc).
    See more Systemic Sclerosis (SSc) experts
  • Distinguished
  • Scleredema
    Dr. Nagaraja is
    Distinguished
    . Learn about Scleredema.
    See more Scleredema experts
  • Scleroma
    Dr. Nagaraja is
    Distinguished
    . Learn about Scleroma.
    See more Scleroma experts
  • Advanced
  • Dermatomyositis
    Dr. Nagaraja is
    Advanced
    . Learn about Dermatomyositis.
    See more Dermatomyositis experts
  • Eosinophilic Fasciitis
    Dr. Nagaraja is
    Advanced
    . Learn about Eosinophilic Fasciitis.
    See more Eosinophilic Fasciitis experts
  • Giant Cell Arteritis (GCA)
    Dr. Nagaraja is
    Advanced
    . Learn about Giant Cell Arteritis (GCA).
    See more Giant Cell Arteritis (GCA) experts
  • Juvenile Temporal Arteritis
    Dr. Nagaraja is
    Advanced
    . Learn about Juvenile Temporal Arteritis.
    See more Juvenile Temporal Arteritis experts
  • Localized Scleroderma
    Dr. Nagaraja is
    Advanced
    . Learn about Localized Scleroderma.
    See more Localized Scleroderma experts
  • Necrotizing Vasculitis
    Dr. Nagaraja is
    Advanced
    . Learn about Necrotizing Vasculitis.
    See more Necrotizing Vasculitis experts
View All 12 Advanced Conditions
  • Experienced
  • Ankylosing Spondylitis
    Dr. Nagaraja is
    Experienced
    . Learn about Ankylosing Spondylitis.
    See more Ankylosing Spondylitis experts
  • Antisynthetase Syndrome
    Dr. Nagaraja is
    Experienced
    . Learn about Antisynthetase Syndrome.
    See more Antisynthetase Syndrome experts
  • Axial Spondyloarthritis (AxSpA)
    Dr. Nagaraja is
    Experienced
    . Learn about Axial Spondyloarthritis (AxSpA).
    See more Axial Spondyloarthritis (AxSpA) experts
  • Bursitis
    Dr. Nagaraja is
    Experienced
    . Learn about Bursitis.
    See more Bursitis experts
  • Calcium Pyrophosphate Arthritis
    Dr. Nagaraja is
    Experienced
    . Learn about Calcium Pyrophosphate Arthritis.
    See more Calcium Pyrophosphate Arthritis experts
  • Eosinophilia-Myalgia Syndrome
    Dr. Nagaraja is
    Experienced
    . Learn about Eosinophilia-Myalgia Syndrome.
    See more Eosinophilia-Myalgia Syndrome experts
View All 33 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved